| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/11/2010 | EP1940246B1 Preventing diseases in infants delivered via caesarean section |
| 08/11/2010 | EP1937688B1 Imidazo benzodiazepine derivatives |
| 08/11/2010 | EP1881979B1 Novel oxadiazole derivatives and their medical use |
| 08/11/2010 | EP1844775B1 Therapeutic agent for the treatment of herpes progenitalis after development of lesions |
| 08/11/2010 | EP1841432B1 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection |
| 08/11/2010 | EP1836201B1 Pyrrolidine inhibitors of iap |
| 08/11/2010 | EP1809605B1 Quinolines as allosteric enhancers of the gaba-b receptors |
| 08/11/2010 | EP1797099B1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 08/11/2010 | EP1797051B1 Benzoxazine and quinoxaline derivatives and uses |
| 08/11/2010 | EP1756076B1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 08/11/2010 | EP1713461B1 Compounds having antitumor activity |
| 08/11/2010 | EP1699766B1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 08/11/2010 | EP1690457B1 Package drink |
| 08/11/2010 | EP1569696B1 Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 08/11/2010 | EP1546083B1 Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them |
| 08/11/2010 | EP1537099B1 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 08/11/2010 | EP1515750B1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/11/2010 | EP1499615B1 Thienyl compounds |
| 08/11/2010 | EP1499294B1 Polymerized lipids modified with peptides used as delivery system for micronutrients |
| 08/11/2010 | EP1492521B1 Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia |
| 08/11/2010 | EP1489170B1 Transporter selectively transporting sulfate conjugate and its gene |
| 08/11/2010 | EP1438073B1 Polyoxyalkylene conjugates as enzyme inhibitors |
| 08/11/2010 | EP1200106B2 Composition containing extracts of butyrospermum parkii and the use as medicament |
| 08/11/2010 | EP1150676B1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 08/11/2010 | EP0672160B1 Activating expression of an amplifying endogenous gene by homologous recombination |
| 08/11/2010 | CN201542233U Multifunctional shape-protecting health care medical pillow for babies |
| 08/11/2010 | CN1997649B Inhibitors of histone deacetylase |
| 08/11/2010 | CN1989992B Compound recipe pharmaceutical composition of traditional Chinese medicine and Western medicine for treating liver diseases |
| 08/11/2010 | CN1977882B Medicinal composition of astragalus, hypericum japonicum thunb. and tiopronin, and its preparing method |
| 08/11/2010 | CN1972696B Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection |
| 08/11/2010 | CN1946727B (Poly) aminoacetamide derivatives of epipodophyllotoxin, their process of preparation and their applications in therapeutics as anticancer agents |
| 08/11/2010 | CN1942179B Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders |
| 08/11/2010 | CN1913897B Novel compound, corresponding compositions, preparation and/or treatment methods |
| 08/11/2010 | CN1899430B Large size Qingkailing dripping pill and its preparing method |
| 08/11/2010 | CN1895547B Medicine for treating diabetes and its preparation |
| 08/11/2010 | CN1886120B Method for the production of a solid, orally applicable pharmaceutical composition |
| 08/11/2010 | CN1875981B Injection emulsion containing breviscapinum and preparation method thereof |
| 08/11/2010 | CN1827600B Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it |
| 08/11/2010 | CN1785247B Disintegrant tablets, and its prepn. method |
| 08/11/2010 | CN1712399B Production and use for taxol and muramic acyl dipeptide conjugate substance of immune reinforcer |
| 08/11/2010 | CN1672745B Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury |
| 08/11/2010 | CN1671357B Short duration depot formulations |
| 08/11/2010 | CN1649551B Drug-delivery endovascular stent and method for treating restenosis |
| 08/11/2010 | CN1429120B Stable polymeric micelle-type drug composition and method for preparation thereof |
| 08/11/2010 | CN101802196A RNAi mediated knockdown of NuMA for cancer therapy |
| 08/11/2010 | CN101802191A Treatment of influenza |
| 08/11/2010 | CN101801991A compounds |
| 08/11/2010 | CN101801983A Triazole compounds that modulate HSP90 activity |
| 08/11/2010 | CN101801982A Macrocyclic indole derivatives for the treatment of hepatitis C infections |
| 08/11/2010 | CN101801981A Sirtuin modulating thiazolopyridine compounds |
| 08/11/2010 | CN101801980A tricyclic heterocyclic derivatives |
| 08/11/2010 | CN101801979A Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof |
| 08/11/2010 | CN101801975A Pyrazolo-pyrazines derivatives used as g protein inhibitors |
| 08/11/2010 | CN101801973A Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 08/11/2010 | CN101801972A Pyrazolo [1,5-A]pyrimidines as inhibitors of stearoyl-coA desaturase |
| 08/11/2010 | CN101801971A Deazapurines useful as inhibitors of janus kinases |
| 08/11/2010 | CN101801970A Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient |
| 08/11/2010 | CN101801969A Indolyl pyrrolidines for the treatment of cancer |
| 08/11/2010 | CN101801968A polymorph forms of (s)-2-((4-benzofuranyl)carbonylaminomethyl)-1-((4-(2-methyl-5-(4-fluorophenyl)thiazolyl)carbonyl)piperidine |
| 08/11/2010 | CN101801967A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same |
| 08/11/2010 | CN101801966A Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 08/11/2010 | CN101801965A Indole compounds as an inhibitor of cellular necrosis |
| 08/11/2010 | CN101801964A Heteroaryl substituted thiazoles and their use as antiviral agents |
| 08/11/2010 | CN101801963A Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 08/11/2010 | CN101801962A Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 08/11/2010 | CN101801961A Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
| 08/11/2010 | CN101801960A prodrugs to thyroid hormone analogs |
| 08/11/2010 | CN101801959A Aminopyrimidines useful as kinase inhibitors |
| 08/11/2010 | CN101801958A Heterocyclic amide compounds as protein kinase inhibitors |
| 08/11/2010 | CN101801957A pyridone gpr119 g protein-coupled receptor agonists |
| 08/11/2010 | CN101801956A Method for modulating GPR119 G protein-coupled receptor and selected compounds |
| 08/11/2010 | CN101801955A Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 08/11/2010 | CN101801954A Compounds and compositions as modulators of GPR119 activity |
| 08/11/2010 | CN101801953A Tetrahydropyridine carboxamide derivatives as TRPVl antagonists |
| 08/11/2010 | CN101801952A N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
| 08/11/2010 | CN101801951A 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones |
| 08/11/2010 | CN101801950A Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 08/11/2010 | CN101801949A Sulfonamides as TRPM8 modulators |
| 08/11/2010 | CN101801947A Ascorbic acid derivative or salt thereof, method for producing the same, and cosmetic preparation |
| 08/11/2010 | CN101801941A Pharmaceutical containing ppar delta agonist |
| 08/11/2010 | CN101801940A Substituted isoxazoline compound and pest control agent |
| 08/11/2010 | CN101801937A Quinazolinone compounds and methods of use thereof |
| 08/11/2010 | CN101801936A metabolites and derivatives of ambrisentan |
| 08/11/2010 | CN101801935A uracil or thymine derivative for treating hepatitis c |
| 08/11/2010 | CN101801933A quinolone derivative |
| 08/11/2010 | CN101801932A Substituted nicotinamide compounds and the use thereof in pharmaceutical products |
| 08/11/2010 | CN101801931A Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 08/11/2010 | CN101801930A 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones |
| 08/11/2010 | CN101801927A Piperidine derivatives as nk3 receptor antagonists |
| 08/11/2010 | CN101801924A Crystalline forms of (r)-1-{2-[4'- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| 08/11/2010 | CN101801923A Pleuromutilin derivatives and their use as antimicrobials |
| 08/11/2010 | CN101801921A Novel sulfamate compounds for medical use |
| 08/11/2010 | CN101801919A Targeting diazo prodrugs for the treatment of gastrointestinal diseases |
| 08/11/2010 | CN101801918A Monoamide derivatives as orexin receptor antagonists |
| 08/11/2010 | CN101801907A Compounds isolated from antrodia cinnamomea and use thereof |
| 08/11/2010 | CN101801901A methods for repelling arthropods using isolongifolenone and/or isologifolenone analogs |
| 08/11/2010 | CN101801520A Process for producing fine particles and the fine particles |
| 08/11/2010 | CN101801461A [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 08/11/2010 | CN101801418A Compositions comprising human EGFR-SIrna and methods of use |
| 08/11/2010 | CN101801417A Macrophage transfection method |